Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older Newer

StormyMonday Free

01/06/09 1:12 PM

Post #143

Re: #142: @mlkrborn - KUDOS!

Thank you... :))

mlkrborn

01/06/09 12:45 PM

Post #142

Re: #139: @StormyMonday - ITS A BUYOUT BABY!!!! Yahooooooooooooooo what a way

KUDOS!

StormyMonday Free

01/06/09 9:20 AM

Post #141

Re: #140: @The_Free_Nebula - yep...that's nice...

What a Fluckin score here...Drinks are on me... Lets go to AC and celebrate YeeeeeHawwwwww

The_Free_Nebula Grandfathered

01/06/09 9:18 AM

Post #140

Re: #139: @StormyMonday - ITS A BUYOUT BABY!!!! Yahooooooooooooooo what a way

yep...that's nice...

StormyMonday Free

01/06/09 9:16 AM

Post #139

Re: #138: @mlkrborn - IDEV sold.. After hours $6.. Told u when

ITS A BUYOUT BABY!!!! Yahooooooooooooooo what a way to start the New Year....Yiiipppeeeeeee

mlkrborn

01/05/09 9:44 PM

Post #138

IDEV sold.. After hours $6.. Told u when it was $1.20..

StormyMonday Free

11/25/08 10:06 AM

Post #137

Re: #132: @drugtester - Hey Stormy...IDEV...you bet!...Still have all my shares purchased

Were moving higher on CEO statements about moving forward in 2009
things are looking much better for resubmission of NEDIBO to the FDA.Also theyare sitting on 131 Mil in cash and marketable securities.
IMHO I think in 2009 NEDIBO gets FDA approval and the shares soar to $10.00 after that a major Pharmaceutical Company buys IDEV or makes a major investment in it.
Best of luck to you and all that had the guts to hold.

0roadrunner Free

09/30/08 11:22 PM

Post #136

Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial
Ryan McBride
9/30/08

Indevus Pharmaceuticals, a Lexington, MA, maker of specialty drugs, says it has launched a Phase 3 clinical trial of an implant designed to provide long-term treatment of patients with acromegaly, a rare and potentially life-threatening condition caused by the overproduction of growth hormone. The company (NASDAQ:IDEV) plans to use its patented “hydron polymer technology” in the implant to outlast Sandostatin LAR injections, the leading current treatment for acromegaly marketed by Switzerland’s Novartis (NYSE:NVS)—pitting the local biotech firm against a global drug giant.

The Indevus implant is inserted under the skin of a patient’s arm at their doctor’s office and is designed to release octreotide—which is a synthetic peptide designed to replicate the growth-hormone-suppressing properties of a natural hormone—for six months. (Indevus already markets to two treatments—Vantas for advanced prostate cancer and Supprelin for early onset of puberty—that use the same polymer technology to allow for this kind of extended release of the drug.) Sandostatin injections also deliver the octreotide peptide, but must be repeated every month.

In the randomized Phase 3 trial, Indevus plans to recruit 140 patients in the U.S. and Europe to, treat them with either octreotide implants or Sandostatin injections, and compare how well the two treatments suppress growth hormone and insulin-like growth factor. Depending on the results of the trial, Indevus says it may be able to launch the implant by early 2011.

It’s unclear what impact the octreotide implant would have on Novartis, which has managed to stave off competition from generic alternatives to Sandostatin, which had 2007 sales of $1.027 billion out of a market of $1.2 billion for such drugs. “This product represents a large commercial opportunity for the company,” says Glenn Cooper, CEO of Indevus, in a statement. He notes that the company plans to begin a Phase 2 trial of the octreotide implant to treat carcinoid syndrome, which is caused when carcinoid tumors secrete such natural chemicals as serotonin into the bloodstream, in early 2009.

Breaking into a well-trodden market with a longer-acting version of an existing drug has brought mixed results for some biotechs. For example, Cambridge, MA-based Alkermes (NASDAQ:ALKS) has seen slow sales of Vivitrol, a once-per-month injection based on generic drug naltrexone to treat alcohol dependence, which is about 10 times as expensive as generic naltrexone and difficult to get reimbursed by health insurers.

http://www.xconomy.com/boston/2008/09/30/indevus-puts-new-acromegaly-treatment-head-to-head-with-novartis-treatment-in-phase-3-trial/

mlkrborn

09/26/08 7:58 PM

Post #135

TEVA backs IDEV now!

stockystumpz Free

09/26/08 1:39 PM

Post #134

Re: #132: @drugtester - Hey Stormy...IDEV...you bet!...Still have all my shares purchased

nice, i got in around same time @1.79 and was very excited to see all of the news when i rolled out of bed this am.

StormyMonday Free

09/26/08 12:31 PM

Post #133

Re: #132: @drugtester - Hey Stormy...IDEV...you bet!...Still have all my shares purchased

Hey drugtester, same here however I did bail out of what I bought
@ $1.19 when I had been buying all the way down last spring. Holding the balance for final FDA results. GLTY, stay in touch and
GO IDEV

drugtester Grandfathered

09/26/08 12:22 PM

Post #132

Re: #131: @StormyMonday - Up 100% to $3.44 on huge news! Hope

Hey Stormy...IDEV...you bet!...Still have all my shares purchased in June @ $1.80.

Congrats!

StormyMonday Free

09/26/08 10:23 AM

Post #131

Re: #127: @drugtester - Good to see the pps @ 2.22. Been

Up 100% to $3.44 on huge news! Hope you held.

Fedex11 ©

09/11/08 9:35 PM

Post #130

Re: #129: @mlkrborn - folks what is your average? trading it or

killed me had calls but alas no go in the timeframe i had looking for an entry though long term

mlkrborn

09/02/08 4:34 PM

Post #129

folks what is your average? trading it or long? what is a fair value to get in?
tia
GLLs

StormyMonday Free

08/29/08 9:28 PM

Post #128

Re: #127: @drugtester - Good to see the pps @ 2.22. Been

Yes nice and steady in the $2.20 - $2.30 range. The earnings still look healthy. Holding for long term.

drugtester Grandfathered

08/19/08 2:13 PM

Post #127

Re: #50: @drugtester - IDEV...I picked up 4,000 PM this am. This

Good to see the pps @ 2.22. Been waiting since mid June for this pop...."+)

StormyMonday Free

08/15/08 8:34 PM

Post #126

Re: #125: @stockystumpz - nice news on patent yesterday after close :D

Nice close today and about time its over $2.00 been waiting for months. Good feeling about the future.

stockystumpz Free

08/14/08 12:50 PM

Post #125

nice news on patent yesterday after close :D

biomanbaba Deceased

07/25/08 12:30 AM

Post #124

I forgot to mention SQNM....given to me by laurap...find her at
white lightening.....best TA board on Ihub IMO

biomanbaba Deceased

07/24/08 11:33 PM

Post #123

I used to own them when they were IPIC....made a killing on the
run from 5 to 50 before the dex recall...now its GERN and COR for me....INGN and TGEN for wild speculation

The_Free_Nebula Grandfathered

07/10/08 11:34 PM

Post #122

Re: #121: @mlkrborn - Hey techno! any opinion as to trade ideas?

Yep...wait and see game now...I suspect it will churn slowly up until the next news cycle...

mlkrborn

07/09/08 1:31 PM

Post #121

Re: #117: @The_Free_Nebula - IDEV - techs looking up...But that date with

Hey techno! any opinion as to trade ideas?
tia

The_Free_Nebula Grandfathered

07/02/08 1:14 AM

Post #120

Re: #117: @The_Free_Nebula - IDEV - techs looking up...But that date with

IDEV - Day 2 post Meeting looking a little better...decent volume to spikes in price RSI is actually back over 30 still waaaay over sold but with life...11 DMA first to fall....bronze crossover with the 20 next week...would be nice..

The_Free_Nebula Grandfathered

06/30/08 8:27 PM

Post #119

Re: #118: @StormyMonday - You called it! Shares responding on very favorable news!

did not end to well though....not sure what folks were expecting but the FDA was not going to say ops we made a mistake...We still may see some churn but slightly to upside...

Make the entire world your Oyster

Boxing - Resurrected ... #board-10274
Let's Talk Basketball .. #board-31

StormyMonday Free

06/30/08 12:54 PM

Post #118

Re: #110: @The_Free_Nebula - IDEV - basing for its next move up

You called it! Shares responding on very favorable news!

The_Free_Nebula Grandfathered

06/23/08 7:46 PM

Post #117

Re: #110: @The_Free_Nebula - IDEV - basing for its next move up

IDEV - techs looking up...But that date with the FDA looms large...

Fedex11 ©

06/22/08 7:39 PM

Post #116

Re: #115: @The_Free_Nebula - Same here...need to get on the other side

yes i agree it will go one way or the other this week we shall see :)

The_Free_Nebula Grandfathered

06/22/08 10:06 AM

Post #115

Re: #114: @Fedex11 © - I agree :) hope to see some uptrend

Same here...need to get on the other side of Friday...If it goes up in anticipation of that FDA meeting there may have been a leak...If it goes down same thing...The uncertainty is likely to keep the price in a narrow horizontal band though.. JMHO

Fedex11 ©

06/22/08 12:57 AM

Post #114

Re: #113: @BMiles - Fedex11, I still have the stock on my

I agree :) hope to see some uptrend this week

BMiles

06/21/08 4:02 PM

Post #113

Re: #111: @Fedex11 © - dont leaveeeeeeee

Fedex11, I still have the stock on my watch list. I kicked myself for holding though it broke through the base of the 15 minute rising trend channel I had previously posted. When it broke south out of the last pennant I posted then I had no choice but to lock in what profit I had left. I still have it on watch, the stock has a lot of potential if timed right.

Brad

Fedex11 ©

06/21/08 1:49 PM

Post #112

Re: #109: @biotek-al - Another way to look at it is the

got to get rid of the shorters and hedgies holding us back :(

Fedex11 ©

06/21/08 1:48 PM

Post #111

Re: #103: @BMiles - Okay, I'm done talking to myself here. :)

dont leaveeeeeeee

The_Free_Nebula Grandfathered

06/21/08 2:49 AM

Post #110

IDEV - basing for its next move up depending on the FDA meeting on the 27th...Probably some leaks may tip its direction...Gambling on calls..

biotek-al

06/20/08 9:54 PM

Post #109

Re: #108: @StormyMonday - Brad, I can't agree with you more on

Another way to look at it is the stock price acted very well today relative to the market and the biotech sector. Today was a pretty brutal day in the overall market you know. I think you guys got it right. The stock is way oversold, undervalued, and will move up. It's no time to give up on a stock showing short term relative strength in a big down market.

Have a good one. All, IMHO of course.

Al

StormyMonday Free

06/20/08 11:53 AM

Post #108

Re: #107: @BMiles - It was a sad play, I thought it

Brad, I can't agree with you more on that statement. Thought the very same as you. I have decided to hold and wait this out to a finanl verdict.
Regards

Joe

BMiles

06/19/08 11:20 PM

Post #107

Re: #106: @The_Free_Nebula - I am not sure the charts tell the

It was a sad play, I thought it had all the right ingredients to really take off but some large institution or large holder has come in and impatiently bid whacked the heck out of it. Still a good play for a rise to $2.50 to $3 but not as quick as I thought it would be.

Brad

The_Free_Nebula Grandfathered

06/19/08 9:28 PM

Post #106

Re: #105: @BMiles - lol... Yeah looking pretty ugly from here, had

I am not sure the charts tell the complete story here Folks simply are not quick to hold profits so soon based on what happened here...Also there is a meeting scheduled for the 27th with the FDA, I dont think folks will rush in knowing that single point failure/questionable success date looms so close ahead...I was hoping to be wrong with the move up but this stall may be based on that....

T

BMiles

06/19/08 9:22 PM

Post #105

Re: #104: @The_Free_Nebula - nothing to say...IDEV is not ready to run yet...

lol... Yeah looking pretty ugly from here, had one more chance to redeem itself today but chose to go the other way. Problem with a wedge is a stock can go either way.

Brad

The_Free_Nebula Grandfathered

06/19/08 9:13 PM

Post #104

Re: #103: @BMiles - Okay, I'm done talking to myself here. :)

nothing to say...IDEV is not ready to run yet...

BMiles

06/19/08 9:04 PM

Post #103

Okay, I'm done talking to myself here. :)

BMiles

06/19/08 10:19 AM

Post #102

Didn't see that coming but on the positive side it should clean out the cobwebs. Perhaps what we just saw was the last flush of shares by the institution who has had this stock capped off the last couple days???

Brad

The info and DD I provide is accurate and factual to the best of my knowledge but still I am human and you should always do your own DD.

Benjamin Franklin once said -
"I am a strong believer in luck and I find the harder I work the more I have of it."

BMiles

06/19/08 9:50 AM

Post #101

15 Minute Chart -

The info and DD I provide is accurate and factual to the best of my knowledge but still I am human and you should always do your own DD.

Benjamin Franklin once said -
"I am a strong believer in luck and I find the harder I work the more I have of it."

BMiles

06/18/08 2:38 PM

Post #100

Here are a couple Pennant Charts to look at -

Just making an educated guess, I am going to say the next pop on this stock will take place between 10:00 AM EST and 11:00 AM EST Thursday morning. Could happen just a little earlier than that but that particular time range is most likely.

Daily Chart -

15 Minute Chart -

Fedex11 ©

06/18/08 8:58 AM

Post #99

Re: #98: @jimmybob - We up! Thats whaddup! weeeeeeeeeeeee!

rofl good morning Jimmy

jimmybob

06/18/08 1:03 AM

Post #98

We up! Thats whaddup! weeeeeeeeeeeee!

BMiles

06/17/08 8:45 PM

Post #97

Re: #96: @The_Free_Nebula - I am surprised etrade does not show that...One

I get it with Alphatrade.

The_Free_Nebula Grandfathered

06/17/08 8:37 PM

Post #96

Re: #95: @BMiles - Looks roughly like about 8,000 shares traded.

I am surprised etrade does not show that...One day I'll complain...thanx...GL...Off to see the game..

BMiles

06/17/08 8:36 PM

Post #95

Re: #94: @The_Free_Nebula - Any way to see how many shares after

Looks roughly like about 8,000 shares traded. Look like it traded down to $1.72 then recovered back to $1.83.

Brad

The_Free_Nebula Grandfathered

06/17/08 8:27 PM

Post #94

Re: #93: @BMiles - Closed up at $1.83 in After-hour trading, I

Any way to see how many shares after hours..? Read on the Yahoo board it was only 1K..; I am thinking we may see green regardless...

Older Newer

INDEVUS PHARMACEUTICALS INC (IDEV)

Followers	4	Posters	22
Posts (Today)	0	Posts (Total)	144
Created	06/05/08	Type	Free
Moderators

We focus on the acquisition, development and commercialization of innovative pharmaceutical products. Our strategy is to focus on the medical specialist, particularly in the areas of urology and endocrinology. Our distinctive product portfolio includes multiple late stage compounds, including treatments for overactive bladder, male hypogonadism, prostate and bladder cancer, central precocious puberty, and the prevention of infection by HIV and other sexually transmitted pathogens